Infliximab monoclonal antibody fragment drug. Targets TNF-alpha, indications for use include crohn's disease, ulcerative colitis, psoriasis, psoriatic

---

Infliximab monoclonal antibody fragment drug. Targets TNF-alpha, indications for use include crohn's disease, ulcerative colitis, psoriasis, psoriatic arthritis, ankylosing spondylitis and rheumatoid arthritis. Generic name and stylized antibody.

---

Size: 9000px × 5261px
Photo credit: © molekuul.be / Alamy / Afripics
License: Royalty Free
Model Released: No

Keywords: ada, alpha, ankylosing, anti-drug, antibody, arthritis, autoimmune, biological, biosimilar, biotech, biotechnology, chimeric, colitis, crohn, disease, drug, factor, immune, immunoglobulin, immunology, immunosuppressant, infliximab, infusion, injection, inn, mab, monoclonal, necrosis, nomenclature, peptide, protein, psoriasis, rheumatoid, spondylitis, tnf, tnf-, tumor, ulcerative